- An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score. Abstract»
- Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis. Abstract»
- Detection of Rheumatoid Arthritis-Interstitial Lung Disease is Enhanced by Serum Biomarkers. Abstract»
- The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis. Abstract»
The purpose of BRASS
The purpose of the Brigham and Women’s Rheumatoid Arthritis Sequential Study (BRASS), under the direction of Dr. Nancy Shadick and Dr. Michael Weinblatt, is to determine how genes can be used to predict whether Rheumatoid Arthritis (RA) will be mild or severe and to better understand how individuals respond to different drug treatments.
BRASS has over 1000 people diagnosed with RA who are patients at the Brigham & Women’s Hospital and who are followed in the clinic annually and sent questionnaires at six month intervals over a 15 year time span. Additionally, BRASS provides investigators with access to subsets of data as well as methodological support.